ArticlePharmaceutics2021

Repurposing of Sitagliptin- Melittin Optimized Nanoformula against SARS-CoV-2: Antiviral Screening and Molecular Docking Studies.

Mohammed W Al-Rabia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.